CCDC106 Activators
CCDC106 can engage in a variety of cellular mechanisms to enhance the protein's functional activity. Forskolin, by directly stimulating adenylyl cyclase, raises intracellular cAMP levels, which in turn can activate protein kinase A (PKA). PKA then can phosphorylate substrates that may include proteins that interact with CCDC106, potentially modulating its function within the cell. Similarly, the cAMP analogs, 8-Br-cAMP and dibutyryl-cAMP, permeate cells and activate PKA, leading to a cascade of phosphorylation events that can affect CCDC106 activity. IBMX, as a non-specific inhibitor of phosphodiesterases, sustains elevated levels of cAMP by preventing its breakdown, indirectly supporting pathways that can enhance CCDC106's activity through sustained PKA activation.
Other chemical activators work through different pathways. PMA and TPA, both activators of protein kinase C (PKC), can initiate phosphorylation of proteins that could interact with CCDC106, influencing its role within signaling pathways. Ionomycin raises intracellular calcium levels and can activate calcium-dependent kinases, which might phosphorylate and thus affect proteins associated with CCDC106. Anisomycin, through its inhibition of protein synthesis, can activate stress-activated protein kinases such as JNK, which in turn can phosphorylate substrates that may include those interacting with CCDC106. Insulin triggers the PI3K/Akt signaling pathway, where Akt-mediated phosphorylation events can impact CCDC106 function. Calyculin A, an inhibitor of protein phosphatases, can enhance the phosphorylation state of proteins by preventing dephosphorylation, thereby indirectly supporting the activation state of CCDC106-associated pathways. Lastly, retinoic acid, by modulating gene expression, can alter protein interactions, which may have an effect on the functional activity of CCDC106 in cellular differentiation processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes responsible for the breakdown of cAMP. By preventing cAMP degradation, IBMX indirectly sustains the activation state of cAMP-dependent pathways, which could enhance the functional activity of CCDC106 through phosphorylation cascades. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is involved in various signaling pathways. PKC activation could lead to the phosphorylation of proteins that interact with or regulate CCDC106, thereby enhancing its functional activity within the cell. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can lead to the activation of cAMP-dependent pathways via G protein-coupled receptor signaling. This cascade can culminate in the activation of PKA, which may phosphorylate and activate proteins that are functionally linked to CCDC106. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a cell-permeable cAMP analog that activates PKA. Activation of PKA could lead to the phosphorylation of regulatory proteins associated with CCDC106, enhancing its functional role in the cell. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs) like JNK. JNK activation can lead to the phosphorylation of substrates that could be involved in the regulation of CCDC106's activity within stress response pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which can activate calcium-dependent kinases such as calmodulin-dependent kinase (CaMK). These kinases might phosphorylate proteins associated with the CCDC106 function, leading to its activation within calcium signaling pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin triggers the PI3K/Akt signaling pathway, which can lead to the phosphorylation and activation of various cellular proteins. Akt-mediated phosphorylation may activate signaling cascades that enhance the functional activity of CCDC106 in metabolic regulation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that activates PKA. Through PKA activation, it might lead to phosphorylation events that enhance the activity of CCDC106 in pathways sensitive to cAMP levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate cellular differentiation and proliferation through the activation of nuclear receptors. This modulation might result in altered protein-protein interactions, potentially enhancing the functional activity of CCDC106 in developmentally regulated processes. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels in the cell. This inhibition could result in enhanced phosphorylation and activation of proteins that regulate or interact with CCDC106, impacting its functional role. | ||||||